Pharmacy Grand Rounds Episode 8: Brexanolone: A New Hope? Updates on the Management of Postpartum Depression
Pharmacy Grand Rounds Podcast |
Mikaela Hofer,Pharm.D. |
In today’s podcast, Dr. Mikaela Hofer, PharmD, (@mikaelamhofer) discusses pathophysiology and treatment options for postpartum depression. With a prevalence ranging from ~6 – 13% per delivery, postpartum depression is relatively common...yet pharmacologic treatments options are sparse. After a review of potential treatment barriers, Dr. Hofer will focus on new treatment targets for postpartum depression, including neurotransmitters and neurosteroids, as well as sharing insight on the potential role of brexanalone for this patient population. |
Learning Objectives
- Identify risk factors associated with postpartum depression
- Review current options for treatment of postpartum depression
- Describe the potential place in therapy for brexanolone in treating postpartum depression
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 0.50 ACPE Knowledge -based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
10/21/2020 | 12/31/2020 | JA0000238-0000-20-060-H01-P |
1/1/2021 | 9/1/2023 | JA0000238-0000-21-034-H01-P |
9/2/2023 | 12/31/2024 | JA0000238-0000-23-083-H01-P |
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. Approval is valid until 12/31/2024. This activity is designated for 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
Available Credit
- 0.50 AAPA Category 1
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Attendance
Price
Registration required to claim CME credit.
Click here to view the online course Cancellation and Refund Policy.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.